Levlen ED CMI - Medsafe
1807 NZ LEVLEN ED CMI 2 . Do not take Levlen ED if you have or have had a blood clot in: • the blood vessels of the legs (deep vein thrombosis - Do not give this medicine to a DVT)
Download Levlen ED CMI - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Report for December 2018 - NACM
web.nacm.orgNACM CMI — 1 — December 2018 Report for December 2018 Issued December 31, 2018 . National Association of Credit Management . Combined Sectors . It can be tempting to read too much into the monthly changes that take place in the Credit Managers’ Index (CMI).
Product Information Plasma-Lyte 148 Replacement IV …
www.baxterhealthcare.com.auPlasma-Lyte 148 Replacement PI 05Jul2013 Page 3 of 8 ccsi41920130326 Baxter In patients with diminished renal function, administration of Plasma-Lyte 148 Replacement IV Infusion may
California Proposition 65 Statement - CMI Enterprises
www.cmi-enterprises.comCalifornia)Proposition65)Statement) Proposition)65)is)aCalifornia)law)thathas)been)in)effectsince)1986)to)promote)clean)drinking) water)and)to)require)businesses)to ...
Medicine NameÒ (phonetic spelling if required)
www.medsafe.govt.nzSofradex CMI NZ 3
CONTINENTAL MOTORS AIRCRAFT ENGINE MANDATORY …
www.tcmlink.comISSUED REVISED. P.O. Box 90 Mobile, AL 251-436-8299. PAGE NO DOC NO REVISION. 1996/08/15 2015/08/10 2 of 2. MSB96-10 . B. II. Inspector Qualification. Ultrasonic inspection of the crankshaft must be performed in accordance with CMI specification